Astrana Health
Stock Forecast, Prediction & Price Target
Astrana Health Financial Estimates
Astrana Health Revenue Estimates
Astrana Health EBITDA Estimates
Astrana Health Earnings per Share Estimates
| Passed | Analyst forecast | ||||||
|---|---|---|---|---|---|---|---|
| Metric | 12/31/2021 | 12/31/2022 | 12/31/2023 | 12/31/2025 | 12/31/2026 | 12/31/2027 | 12/31/2028 |
Revenue
% change YoY
| $773.91M N/A | $1.14B 47.84% | $1.38B 21.19% | Avg: $2.12B Low: $1.98B High: $2.17B avg. 53.42% | Avg: $2.41B Low: $2.27B High: $2.61B avg. 13.52% | Avg: $2.31B Low: $2.17B High: $2.50B avg. -4.24% | Avg: $2.51B Low: $2.37B High: $2.72B avg. 8.80% |
Net Income
% change YoY
| $68.92M N/A | $45.17M -34.46% | $60.71M 34.41% | Avg: $84.65M Low: $71.82M High: $105.62M avg. 39.42% | Avg: $121.68M Low: $88.72M High: $126.27M avg. 43.74% | Avg: $107.96M Low: $99.81M High: $119.45M avg. -11.27% | Avg: $130.97M Low: $121.07M High: $144.90M avg. 21.30% |
EBITDA
% change YoY
| $109.21M N/A | $133.35M 22.10% | $123.68M -7.24% | Avg: $235.27M Low: $219.28M High: $240.98M avg. 90.21% | Avg: $267.09M Low: $251.57M High: $288.95M avg. 13.52% | Avg: $255.77M Low: $240.90M High: $276.70M avg. -4.24% | Avg: $278.28M Low: $262.11M High: $301.06M avg. 8.80% |
EPS
% change YoY
| $1.57 N/A | $1 -36.30% | $1.3 30.00% | Avg: $1.77 Low: $1.53 High: $2.25 avg. 36.15% | Avg: $2.29 Low: $1.89 High: $2.69 avg. 29.37% | Avg: $2.3 Low: $2.13 High: $2.54 avg. 0.43% | Avg: $2.79 Low: $2.58 High: $3.09 avg. 21.30% |
Operating Expenses
% change YoY
| $79.59M N/A | $95.21M 19.62% | $130.34M 36.89% | Avg: $145.93M Low: $136.01M High: $149.47M avg. 11.96% | Avg: $165.67M Low: $156.05M High: $179.23M avg. 13.52% | Avg: $158.65M Low: $149.43M High: $171.63M avg. -4.24% | Avg: $172.61M Low: $162.58M High: $186.74M avg. 8.80% |
FAQ
What is Astrana Health stock earnings growth forecast?
Wall Street analysts estimate the annual average earnings growth rate of 23.30% in 2025-2028.
We have gathered data from 6 analysts. Their low estimate is 71.82M, average is 84.65M and high is 105.62M.
What is Astrana Health stock revenue growth forecast?
Wall Street analysts forecast annual average revenue growth of 17.87% in 2025-2028.
We have gathered data from 6 analysts. Their low revenue estimate is $1.98B, average is $2.12B and high is $2.17B.
What is Astrana Health stock earnings per share growth forecast?
Wall Street analysts forecast annual average earnings growth of 21.81% in 2025-2028.
We have gathered data from 6 analysts. Their low earnings per share estimate is $1.53, average is $1.77 and high is $2.25.
What is the best performing analyst?
In the last twelve months analysts have been covering Astrana Health stock. The most successful analyst is Chris O`Cull.